MedPath

Effect of Dexamethasone soaked nasalpack on postoperative pain of patients undergoing Dacryocystorhinostomy surgery

Phase 3
Recruiting
Conditions
H04.559
acrimal duct obstruction.
Acquired stenosis of unspecified nasolacrimal duct
Registration Number
IRCT20210113050021N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
112
Inclusion Criteria

Age between 18 and 75 years old and able to speak Persian, patient candidate for dacryocystorhinostomy surgery, patients with class 1 and 2 anesthesia (ASA), no history of systemic hypertension based on history, no history of known and confirmed Psychological disease based on history, no history of current seizures based on history, no history of alcohol or drug abuse, no use of any painkillers in 24 hours before surgery

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain in the first 24 hours after surgery. Timepoint: 0, 3, 6, 12, 18 and 24 hours after surgery. Method of measurement: Pain intensity is assessed by the grading scale used in the NHS system of Wales University Hospital. This scale has 4 degrees: if the patient expresses complete pain relief, the pain intensity is zero and if the patient expresses severe pain, the patient's pain intensity is 3. At this scale, the patient's pain intensity is asked and the patient's description of the pain experienced is marked in one of four categories: painless, mild, moderate, severe..
Secondary Outcome Measures
NameTimeMethod
Dosage in mg of rescue analgesia (morphine / pethidine / methadone / apotel / ketorolac / indomethacin). Timepoint: 0, 3, 6, 12, 18 and 24 hours after surgery. Method of measurement: questionnaire.;The interval between the first use of adjuvant painkillers and the end of the operation. Timepoint: In the first 24 hours after surgery. Method of measurement: Patient statement.
© Copyright 2025. All Rights Reserved by MedPath